Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries

Elci E., Kaya C., Cim N., Yildizhan R., Elci G. G.

GYNECOLOGICAL ENDOCRINOLOGY, vol.33, no.1, pp.43-47, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.1080/09513590.2016.1203893
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.43-47
  • Van Yüzüncü Yıl University Affiliated: Yes


Objective: To compare cardiac risk markers such as asymmetric dimethyl arginine (ADMA), C-reactive protein (CRP), homocystein (Hcy), plasminogen activator inhibitor-1 (PAI-1), vascular endothelial growth factor (VEGF), angiopoietin-related growth factor 6 (ANGPTL6) in obese and non-obese patients with polycystic ovary syndrome (PCOS).